Can You Combine a Senior Longevity Chew With a Joint Supplement?

By Justin Shmalberg, DVM, CVA, ACVN, ACVSMR

✓ Medically reviewed by Justin Shmalberg, DVM, CVA, ACVN, ACVSMR — August 17, 2026 For general education — not a substitute for veterinary care.

Comparisons · August 15, 2026 · 5 min read

Yes, you can usually combine them — but stacking two senior supplements only pays off if you know what each one is actually doing.

A twelve-year-old cattle dog named Piper came in for her spring wellness visit with a shoebox of supplement bottles balanced on the owner’s lap — a glucosamine-chondroitin chew, a fish oil, and a newer NAD+ precursor chew she’d started after reading about canine longevity trials. The owner’s question was blunt: was she overdoing it, or was this actually a reasonable senior-dog stack?

I get a version of that question most weeks now. Longevity chews built around NAD+ precursors have moved fast from niche to mainstream, and they’re landing in households that already have a joint supplement in the cabinet. The honest answer is that combining the two is rarely dangerous, but it deserves more thought than “more support is always better.”

What each supplement is actually built to do

A joint supplement — usually glucosamine, chondroitin, or a marine-derived omega blend — is aimed at cartilage matrix and inflammatory signaling in and around a joint. A longevity chew built on nicotinamide riboside or nicotinamide mononucleotide is aimed at something else entirely: restoring cellular NAD+ levels, which decline with age and are tied to mitochondrial and metabolic function. These are not competing products chasing the same outcome. They’re addressing different physiology, which is precisely why stacking them isn’t automatically redundant.

That distinction matters because owners often assume “senior support” is one bucket. It isn’t. A dog’s cartilage doesn’t regenerate because its cellular energy metabolism improves, and a dog’s NAD+ pool doesn’t rise because you added chondroitin. If you’re choosing between the two supplement categories rather than combining them, this publication’s breakdown of Glucosamine vs. MSM for Dog Joint Pain: What the Evidence Actually Supports lays out where each ingredient’s evidence is strongest.

Where the evidence for each ingredient actually stands

I don’t treat glucosamine and chondroitin as settled science, and neither should you. A 2017 review of glucosamine and chondroitin use in canine osteoarthritis, published via PubMed, found the veterinary trial base thin and the results inconsistent — some studies show measurable pain and weight-bearing improvement, others show none. A more recent randomized, block-controlled trial comparing glucosamine-chondroitin, a marine fatty acid blend, and carprofen in dogs with hip osteoarthritis, indexed on PMC, found glucosamine-chondroitin did not significantly outperform placebo on weight-bearing measures the way the NSAID did. That’s not a reason to abandon it. It’s a reason to treat it as a structure/function supplement with modest, individually variable benefit rather than a guaranteed fix.

The NAD+ precursor category is younger but has real data behind it. A randomized, controlled clinical trial combining a senolytic with an NAD+ precursor in senior dogs, published in Nature, reported owner-assessed improvements in cognitive function over the study period. That’s a meaningful result for a supplement class that, a few years ago, had almost no dog-specific trial data at all. It’s still one trial, in a specific combination, measuring owner-reported outcomes — not a settled verdict on every NAD+ chew on the market.

If you’re trying to decide whether the newer NAD+ category is worth adding at all, our comparison of NAD+ Precursor Chews vs. Fish Oil for Senior Dog Vitality walks through that evidence gap directly, and it’s worth reading before you add a third product to the shelf.

What I actually watch for when a dog is on both

In my practice, the dogs who do best on a combined stack are the ones whose owners are tracking something specific, not just adding products on faith. One patient — a fourteen-year-old Lab mix named Gus, roughly 78 pounds, who’d started struggling with the two stairs into his owner’s kitchen — had been on a glucosamine chew for over a year with modest, plateaued benefit. His owner added an NAD+ precursor chew that winter, mainly hoping for better energy and sleep, not joint change. Over about six weeks she noted he was more willing to initiate a walk and seemed to settle faster at night. I want to be clear that’s one dog’s course, not a study result, and I don’t present it as proof the combination “worked” in any generalizable sense. But it illustrates the kind of tracking that actually tells you something: stairs, willingness to walk, sleep pattern, stool, appetite. Vague impressions of “seems better” don’t give you or your vet anything to act on.

Short version: combining is about tracking two different outcomes, not doubling down on one.

Dose stacking is the other real consideration. These products rarely share overlapping active ingredients, so you’re not typically doubling up on the same compound the way you might with two omega-3 products. Still, form matters — a chew-plus-chew regimen adds up in calories and volume for a small dog, and pill burden or palatability fatigue is a real reason some owners quietly stop giving one of the two. If you’re weighing chew formats specifically, Chew vs Powder vs Liquid Supplements for Dogs: Which Form Is Most Effective covers how absorption and consistency can differ by delivery form, which is worth knowing before you commit to two chews a day long-term.

I also tell owners to check for a quality seal from the National Animal Supplement Council on each product independently — NASC certification verifies manufacturing and adverse-event reporting standards, but it verifies each product on its own; it says nothing about how two certified products behave together in your specific dog, especially one on other medications.

The verdict

Here’s where the counterargument deserves real weight: some clinicians will tell you a senior dog on multiple daily supplements is just expensive redundancy, and that owners would be better served putting that budget toward one well-dosed joint product and a veterinary orthopedic exam. I understand that position, and for dogs with mild, early stiffness and no other aging concerns, it’s often right. But I don’t think it holds for every senior dog, because a joint supplement and an NAD+ precursor are answering different physiological questions — one is about cartilage and local inflammation, the other about cellular energy metabolism as a dog ages. For a dog like Piper, with both joint stiffness and the kind of global slowdown owners describe as “just seeming old,” I land on cautious, trackable combination: keep the joint supplement for its structure/function role in mobility, add the NAD+ precursor deliberately rather than reflexively, and hold both to the same standard — a defined outcome you’re actually watching for, reassessed every eight to twelve weeks with your vet. Where the evidence is strongest is glucosamine-chondroitin’s long safety record with modest, individually variable benefit; where it’s thinnest is any claim that stacking accelerates results. Looking ahead, as more NAD+ precursor trials in dogs are published, I expect the case for thoughtful combination — not blanket stacking — to only get clearer.